CD274 and neoplasm: As one of the immune checkpoint molecules, PD-L1 expressed on tumor cells interacts with its receptor programmed death 1 (PD-1) expressed on CTLs, leading to inhibition of CTLs-mediated anti-tumor immune responses [52,53].